Citations

Clear

6273 citation(s) found for "To, Andrew".

Association of Integrin α2 Gene Variants with Ischemic Stroke
Matarín, Mar, Brown, W. Mark , Hardy, John , Rich, Stephen S. , Singleton, Andrew , Brown, Robert D., Brott, Thomas G. , Worrall, Bradford B. , ISGS, SWISS, Groups, MSGD Study, Meschia, James F. , ISGS, SWISS, Groups, MSGD Study, Rich, Stephen S , Hardy, John

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | May 30, 2007 | Volume: 28 | Issue: 1 | Pages: 81-89

10.1038/sj.jcbfm.9600508 | PMID 17534386 Get It

Genetic variants in the gene encoding integrin α2 ( ITGA2) have been reported to be associated with an increased risk for ischemic stroke. The purpose of this study was to investigate the association between haplotype-tagging single-nucleotide polymorphisms (tSNPs) in ITGA2 and risk of ischemic stroke in a collection of North American stroke cases and controls. The study included 484 cases and 263 controls. Thirteen tSNPs were genotyped. Association tests at and across each tSNP were performed, including haplotype association analysis. Secondary analyses considered stroke subtypes on the basis of Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. We observed significant association between tSNP rs3756541 (additive model, odds ratio (OR), 1.49; 95% confidence interval (CI), 1.11 to 2.04; P = 0.009) and disease and a trend toward association at rs2303124 (recessive model, OR, 1.56; 95% CI, 1.05 to 2.33; P = 0.03). These associations remained significant in the haplotype analyses. The associated tSNPs did not distinguish stroke etiology after application of TOAST criteria. Our results suggest that genetic variability within ITGA2 may confer risk for ischemic stroke independent of conventional risk factors. These results provide additional support for a role for platelet receptor genes in the pathogenesis of ischemic stroke of diverse subtypes.
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
Stephenson, Andrew J. , Scardino, Peter T. , Kattan, Michael W. , Pisansky, Thomas M. , Slawin, Kevin M., Klein, Eric A. , Anscher, Mitchell S. , Michalski, Jeff M. , Lin, Daniel W. , Forman, Jeffrey D., Zeléfsky, Michael J. , Kestin, Larry L. , Roehrborn, Claus G. , Catton, Charles , DeWeese, Theodore L. , Liauw, Stanley L. , Valicenti, Richard K., Kuban, Deborah A., Pollack, Alan , Sandler, Howard M. , Klein, Eric A , Liauw, Stanley L , Kattan, Michael W

Mayo Clinic

Journal of Clinical Oncology | May 19, 2007 | Volume: 25 | Issue: 15 | Pages: 2035-2041

10.1200/jco.2006.08.9607 | PMID 17513807 Get It

Purpose An increasing serum prostate-specific antigen (PSA) level is the initial sign of recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation therapy (SRT) may eradicate locally recurrent cancer, but studies to distinguish local from systemic recurrence lack adequate sensitivity and specificity. We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence. Patients and Methods Using multivariable Cox regression analysis, we constructed a model to predict the probability of disease progression after SRT in a multi-institutional cohort of 1,540 patients. Results The 6-year progression-free probability was 32% (95% CI, 28% to 35%) overall. Forty-eight percent (95% CI, 40% to 56%) of patients treated with SRT alone at PSA levels of 0.50 ng/mL or lower were disease free at 6 years, including 41% (95% CI, 31% to 51%) who also had a PSA doubling time of 10 months or less or poorly differentiated (Gleason grade 8 to 10) cancer. Significant variables in the model were PSA level before SRT (P < .001), prostatectomy Gleason grade (P < .001), PSA doubling time (P < .001), surgical margins (P < .001), androgen-deprivation therapy before or during SRT (P < .001), and lymph node metastasis (P = .019). The resultant nomogram was internally validated and had a concordance index of 0.69. Conclusion Nearly half of patients with recurrent prostate cancer after radical prostatectomy have a long-term PSA response to SRT when treatment is administered at the earliest sign of recurrence. The nomogram we developed predicts the outcome of SRT and should prove valuable for medical decision making for patients with a rising PSA level.
Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
Gill, Inderbir S. , Kavoussi, Louis R., Lane, Brian R. , Blute, Michael L., Babineau, Denise C. , Colombo, José R. , Frank, Igor, Permpongkosol, Sompol, Weight, Christopher , Kaouk, Jihad , Kattan, Michael W. , Novick, Andrew C. , Kattan, Michael W , Gill, Inderbir S

Mayo Clinic

Journal of Urology | May 12, 2007 | Volume: 178 | Issue: 1 | Pages: 41-46

10.1016/j.juro.2007.03.038 | PMID 17574056 Get It

A 46-year-old woman with severe weakness following acute respiratory distress syndrome
Waclawik, Andrew J., Selcen, Duygu , Keegan, B. Mark

Mayo Clinic

Neurology | April 30, 2007 | Volume: 68 | Issue: 18 | Pages: 1529-1535

10.1212/01.wnl.0000264501.23633.8d | PMID 17470757 Get It

IDOCS: Intelligent Distributed Ontology Consensus System—The Use of Machine Learning in Retinal Drusen Phenotyping
Thomas, George, Grassi, Michael A. , Lee, John R. , Edwards, Albert O., Casavant, Thomas L. , Scheetz, Todd E. , Stone, Edwin M. , Williams, Andrew B. , Gorin, Michael B. , Klein, Ronald

Mayo Clinic

Investigative Opthalmology & Visual Science | April 25, 2007 | Volume: 48 | Issue: 5 | Pages: 2278

10.1167/iovs.06-1022 | PMID 17460291 Get It

Human Immunodeficiency Virus Type 1 Protease Cleaves Procaspase 8 In Vivo
Nie, Zilin , Bren, Gary D., Vlahakis, Stacey R., Schimnich, Alicia Algeciras, Brenchley, Jason M. , Trushin, Sergey A., Warren, Sarah , Schnepple, David, Kovacs, Colin , Loutfy, Mona , Douek, Daniel C. , Badley, Andrew D. , Badley, Andrew D

Mayo Clinic

Journal of Virology | April 19, 2007 | Volume: 81 | Issue: 13 | Pages: 6947-6956

10.1128/jvi.02798-06 | PMID 17442709 Get It

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) infection causes apoptosis of infected CD4 T cells as well as uninfected (bystander) CD4 and CD8 T cells. It remains unknown what signals cause infected cells to die. We demonstrate that HIV-1 protease specifically cleaves procaspase 8 to create a novel fragment termed casp8p41, which independently induces apoptosis. casp8p41 is specific to HIV-1 protease-induced death but not other caspase 8-dependent death stimuli. In HIV-1-infected patients, casp8p41 is detected only in CD4 + T cells, predominantly in the CD27 + memory subset, its presence increases with increasing viral load, and it colocalizes with both infected and apoptotic cells. These data indicate that casp8p41 independently induces apoptosis and is a specific product of HIV-1 protease which may contribute to death of HIV-1-infected cells.
Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer
Gayther, Simon A. , Song, Honglin , Ramus, Susan J. , Kjær, Susanne K. , Whittemore, Alice S. , Quaye, Lydia, Shadforth, Danielle, Høgdall, Estrid , Høgdall, Claus , Blaeker, Jan, DiCioccio, Richard A., McGuire, Valerie , Webb, Penelope M. , Beesley, Jonathan, Whiteman, David C. , Group, The Australian Ovarian Cancer Study, Cancer), The Australian Cancer Study (Ovarian, Goodman, Marc T. , Lurie, Galina, Carney, Michael E., Ness, Roberta B., Edwards, Robert P., Moysich, Kirsten B., Goode, Ellen L. , Cunningham, Julie M. , Sellers, Thomas A. , Wu, Anna H. , Pike, Malcolm C. , Iversen, Edwin S., Marks, Jeffrey R. , García‐Closas, Montserrat , Brinton, Louise A. , Lissowska, Jolanta , Pepłońska, Beata , Easton, Douglas F. , Jacobs, Ian , Ponder, Bruce A.J., Schildkraut, Joellen M. , Pearce, Celeste Leigh, Chenevix‐Trench, Georgia , Pharoah, Paul D.P., Blaakær, Jan , Tyrer, Jonathan P. , Green, Adèle C. , Group, The Australian Ovarian Cancer Study, Cancer), The Australian Cancer Study (Ovarian, Modugno, Francesmary , Couch, Fergus J. , Berchuck, Andrew , Kjaer, Susanne K , Ramus, Susan J , Webb, Penelope M , Moysich, Kirsten , Lissowska, Jolanta , García-Closas, Montserrat , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Whiteman, David C , Goodman, Marc T

Mayo Clinic

Cancer Research | April 4, 2007 | Volume: 67 | Issue: 7 | Pages: 3027-3035

10.1158/0008-5472.can-06-3261 | PMID 17409409 Get It

Abstract High-risk susceptibility genes explain &lt;40% of the excess risk of familial ovarian cancer. Therefore, other ovarian cancer susceptibility genes are likely to exist. We have used a single nucleotide polymorphism (SNP)–tagging approach to evaluate common variants in 13 genes involved in cell cycle control—CCND1, CCND2, CCND3, CCNE1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, and CDKN2D—and risk of invasive epithelial ovarian cancer. We used a two-stage, multicenter, case-control study. In stage 1, 88 SNPs that tag common variation in these genes were genotyped in three studies from the United Kingdom, United States, and Denmark (∼1,500 cases and 2,500 controls). Genotype frequencies in cases and controls were compared using logistic regression. In stage 2, eight other studies from Australia, Poland, and the United States (∼2,000 cases and ∼3,200 controls) were genotyped for the five most significant SNPs from stage 1. No SNP was significant in the stage 2 data alone. Using the combined stages 1 and 2 data set, CDKN2A rs3731257 and CDKN1B rs2066827 were associated with disease risk (unadjusted P trend = 0.008 and 0.036, respectively), but these were not significant after adjusting for multiple testing. Carrying the minor allele of these SNPs was found to be associated with reduced risk [OR, 0.91 (0.85–0.98) for rs3731257; and OR, 0.93 (0.87–0.995) for rs2066827]. In conclusion, we have found evidence that a single tagged SNP in both the CDKN2A and CDKN1B genes may be associated with reduced ovarian cancer risk. This study highlights the need for multicenter collaborations for genetic association studies. [Cancer Res 2007;67(7):3027–35]
The Use of Routine Wrist Radiography is Not Useful in the Evaluation of Patients with a Ganglion Cyst of the Wrist
Wong, Andrew S., Jebson, Peter, Murray, Peter M. , Trigg, S.D.

Mayo Clinic

HAND | March 29, 2007 | Volume: 2 | Issue: 3 | Pages: 117-119

10.1007/s11552-007-9032-8 | PMID 18780070 Get It

The purpose of this study was to evaluate the cost-effectiveness of routine wrist radiography in the evaluation of patients with a wrist ganglion. In the setting of a University-based hand surgery practice, 103 consecutive patients with a dorsal or volar wrist ganglion underwent posteroanterior, lateral, and oblique radiographs of the involved wrist. There were 24 men and 79 women with an average age of 34 years (range 4–67 years). A retrospective review of the medical records was performed. Abnormalities on plain radiographs were noted in only 13 patients (13%). Findings included six cases of thumb carpometacarpal joint arthritis and one case each of an enchondroma, congenital distal radioulnar joint (DRUJ) anomaly, DRUJ degenerative changes, intraosseous ganglion, carpal boss, radiocarpal arthritis, and thumb metacarpophalangeal joint osteoarthritis. In only one case (1%) did the findings alter the management. At our institution, the professional and technical charge for three views of the wrist is $172. This confers a cost of $17,716 per therapeutically significant finding in our series. We conclude that routinely performing wrist radiography is not cost-effective in the evaluation and treatment decision-making process in patients with a wrist ganglion.
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Morton, Lindsay M. , Turner, Jennifer , Cerhan, James R. , Linet, Martha S. , Treseler, Patrick, Jack, Andrew , Spinelli, John J., Costantini, Adele Seniori , Rüdiger, Thomas , Scarpa, Aldo , Zheng, Tongzhang, Weisenburger, Dennis D. , Clarke, Christina A. , Cozen, Wendy , Maynadié, Marc , Cerhan, James R , Turner, Jennifer , Morton, Lindsay M

Mayo Clinic

Blood | March 28, 2007 | Volume: 110 | Issue: 2 | Pages: 695-708

10.1182/blood-2006-11-051672 | PMID 17389762 Get It

Abstract Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.
Prevalence of erectile dysfunction in vascular surgery patients
Falkensammer, Juergen , Hakaim, Albert G., Falkensammer, Claudia E., Broderick, Gregory A. , Oldenburg, W. Andrew, Hugl, Beate, Crook, Julia E. , Heckman, Michael G.

Mayo Clinic

Vascular Medicine | March 22, 2007 | Volume: 12 | Issue: 1 | Pages: 17-22

10.1177/1358863x06076043 | PMID 17451089 Get It

Erectile dysfunction (ED) is frequently associated with cardiovascular disease. Epidemiological data on the frequency of ED in vascular surgery patients is rarely reported. We evaluated the prevalence of this comorbidity in patients consulting the vascular surgery outpatient clinic. Over a 6-month period, a short version of the International Index of Erectile Function (IIEF) questionnaire consisting of six EDrelevant questions was handed out to 440 vascular surgery outpatients. Clinical data were collected from patients' records. Linear regression models with forward selection were used to investigate associations between erectile function score and possible risk factors. The return rate was 31% (137 patients). Eight patients (6%) were taking phosphodiesterase inhibitors. ED, as defined by an erectile function score of 25 or less and/or use of phosphodiesterase inhibitors, was found in 90% (95% CI: 84% to 95%) of cases. Moderate or severe ED, as defined by an erectile function score of 16 or less and/or use of phosphodiesterase inhibitors, was found in 70% (95% CI: 62% to 78%) of cases. Increased age, abdominal aortic aneurysm, peripheral arterial disease, urologic disease, insulin-dependent diabetes mellitus, and use of beta-blockers were significantly associated with a lower erectile function score. In conclusion, erectile dysfunction is a frequent and often missed comorbidity in vascular surgery patients. While ED may have a profound impact on the patient's quality of life, attention should also be paid to the patient's preoperative sexual function, considering the availability of oral pharmacotherapies and possible consequences concerning liability in postoperative patients in whom pre-existing ED was not identified properly.